RJA
SAVAW

Raymond James & Associates’s Cassava Sciences, Inc. Warrant SAVAW Stock Holding History

Raymond James & Associates’s Portfolio SAVAW Stock Details SAVAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-28,885
Closed -$116K – 4127
2024
Q1 		$116K Buy
+28,885
New +$173K ﹤0.01% 3715

Other funds holding SAVAW

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Raymond James & Associates's SAVAW Position: Q2 2024 in Review

Raymond James & Associates sold out of Cassava Sciences, Inc. Warrant (SAVAW) in Q2 2024, closing a stake of 28,885 shares — an estimated $116K sold.

Raymond James & Associates first reported a position in SAVAW in Q1 2024 and held it in 1 quarter. The position peaked at $116K in Q1 2024. 3 funds tracked by Wall St. Rank hold SAVAW as of Q2 2024.

  • Raymond James & Associates reported no remaining Cassava Sciences, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
  • Raymond James & Associates sold 28,885 Cassava Sciences, Inc. Warrant shares in Q2 2024, an estimated $116K.
  • Raymond James & Associates first reported a position in Cassava Sciences, Inc. Warrant in Q1 2024 and held it in 1 quarter.
  • Raymond James & Associates's Cassava Sciences, Inc. Warrant position peaked at $116K in Q1 2024.
  • 3 funds tracked by Wall St. Rank held Cassava Sciences, Inc. Warrant as of Q2 2024.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.